Number of the records: 1  

gamma H2AX/53BP1 foci as a potential pre-treatment marker of HNSCC tumors radiosensitivity preliminary methodological study and discussion

  1. 1.
    SYSNO ASEP0485555
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    Titlegamma H2AX/53BP1 foci as a potential pre-treatment marker of HNSCC tumors radiosensitivity preliminary methodological study and discussion
    Author(s) Falk, Martin (BFU-R) RID, ORCID
    Hořáková, Z. (CZ)
    Svobodová, M. (CZ)
    Masařík, M. (CZ)
    Kopečná, Olga (BFU-R) ORCID
    Gumulec, J. (CZ)
    Raudenská, M. (CZ)
    Depeš, Daniel (BFU-R)
    Bačíková, Alena (BFU-R)
    Falková, Iva (BFU-R) ORCID
    Binkova, H. (CZ)
    Number of authors11
    Article number241
    Source TitleEuropean Physical Journal D. - : Springer - ISSN 1434-6060
    Roč. 71, č. 9 (2017)
    Number of pages7 s.
    Publication formOnline - E
    Languageeng - English
    CountryDE - Germany
    Keywordssquamous-cell carcinoma ; cancer-associated fibroblasts
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsGA16-12454S GA ČR - Czech Science Foundation (CSF)
    Institutional supportBFU-R - RVO:68081707
    UT WOS000411083200015
    DOI10.1140/epjd/e2017-80073-2
    AnnotationIn order to improve patients' post-treatment quality of life, a shift from surgery to non-surgical (chemo) radio-treatment is recognized in head and neck oncology. However, about half of HNSCC tumors are resistant to irradiation and an efficient marker of individual tumor radiosensitivity is still missing. We analyzed whether various parameters of DNA double strand break (DSB) repair determined in vitro can predict, prior to clinical treatment initiation, the radiosensitivity of tumors. We compared formation and decrease of gamma H2AX/53BP1 foci in 48 h after irradiating tumor cell primocultures with 2 Gy of gamma-rays. To better understand complex tumor behavior, three different cell type primocultures CD90(-), CD90(+), and a mixed culture of these cells were isolated from 1 clinically radioresistant, 2 radiosensitive, and 4 undetermined HPV-HNSCC tumors and followed separately. While DSB repair was delayed and the number of persisting DSBs increased in the radiosensitive tumors, the results for the radioresistant tumor were similar to cultured normal human skin fibroblasts. Hence, DSB repair kinetics/efficiency may correlate with clinical response to radiotherapy for a subset of HNSCC tumors but the size (and therefore practical relevance) of this subset remains to be determined. The same is true for contribution of different cell type primocultures to tumor radioresistance.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.